Medication-assisted treatment, often shortened to MAT, uses FDA-approved medications to treat opioid use disorder, alcohol use disorder, and certain other substance use disorders. Depending on the condition, medication can reduce withdrawal symptoms, ease opioid or alcohol cravings, block euphoric effects, improve treatment retention, and reduce the risk of opioid overdose. MAT is not about replacing willpower with medication. Substance use disorders are medical conditions that can affect brain function, behavior, physical health, relationships, and daily life. Kentucky Addiction Treatment provides educational information about medication-assisted treatment, addiction treatment, mental health, and recovery options so individuals and families can better understand how medication may fit into a broader treatment plan.
TABLE OF CONTENTS
What is medication-assisted treatment?
Medication-assisted treatment is one of several therapies for addiction that can help address the physical and behavioral aspects of substance use disorders. The term traditionally refers to the use of medication alongside counseling, behavioral therapies, recovery support, and medical care tailored to an individual’s needs.
For opioid use disorder, clinicians and federal agencies increasingly use the term medications for opioid use disorder, or MOUD. The U.S. Food and Drug Administration recognizes three FDA-approved medications for OUD: methadone, buprenorphine, and naltrexone. All three are evidence-based treatment options, although they work in different ways and are not appropriate for every person.
Counseling and behavioral support can be valuable parts of recovery, but medication for opioid use disorder should remain accessible even when someone cannot participate in counseling. Treatment pathways should reflect medical history, opioid use, mental health, treatment goals, available support, and individual preference.
Medication-assisted treatment and opioid use disorder
Opioid use disorder, or OUD, is a chronic medical condition involving continued opioid use despite significant harm or difficulty controlling use. It may develop after misuse of prescription pain relievers, heroin, fentanyl, or other illicit opioids.
Medication can help reduce opioid withdrawal and psychological cravings while lowering the likelihood of returning to uncontrolled opioid use. The Centers for Disease Control and Prevention states that medication treatment for OUD is associated with lower overdose risk and reduced overall mortality.
Detoxification by itself is not considered sufficient treatment for opioid use disorder. After tolerance declines, returning to previous opioid use can sharply increase overdose risk. Ongoing medication treatment can provide a more stable foundation for long-term recovery.
Reach out for answers and help. We’re here for you 24 hours a day, 7 days a week.
FDA-approved medications for opioid use disorder
There are three FDA-approved medication categories used to treat opioid use disorder: methadone, buprenorphine, and naltrexone. The appropriate MAT medication depends on opioid use, withdrawal status, medical conditions, treatment history, access, and personal preference.
| Medication | Medication type | How it may help | Important consideration |
|---|---|---|---|
| Methadone | Full opioid agonist | Reduces opioid withdrawal and cravings | For OUD, methadone is generally dispensed through federally certified opioid treatment programs |
| Buprenorphine | Partial opioid agonist | Reduces withdrawal and cravings with a ceiling effect on some opioid effects | Available in several formulations, including long-acting injections |
| Naltrexone | Opioid antagonist | Blocks opioid receptors and prevents euphoric effects from opioids | A person must be opioid-free before initiation to avoid precipitated withdrawal |
These medications do not all work in the same way. Methadone and buprenorphine activate opioid receptors to different degrees, while naltrexone is an opioid antagonist that blocks them.
Physical dependence on methadone or buprenorphine is also not the same as uncontrolled addiction. Physical dependence means the body adapts to a medication and may develop withdrawal symptoms if it is stopped suddenly. Addiction involves patterns such as loss of control, compulsive use, and continued use despite harm.
How buprenorphine helps treat opioid use disorder
Buprenorphine is a partial opioid agonist. It activates opioid receptors enough to reduce withdrawal symptoms and cravings while producing a ceiling effect on some opioid effects. This pharmacology can help stabilize people who have developed opioid dependence without reproducing the same pattern associated with uncontrolled use of full-agonist illicit opioids.
Buprenorphine is available in several formulations, including tablets, films, and extended-release injections. Some formulations combine buprenorphine with naloxone. Healthcare practitioners consider factors such as current opioid use, withdrawal status, medical history, and other medications before prescribing it.
The former federal buprenorphine waiver, commonly called the X-waiver, is no longer required. Federal law changed in 2022, and practitioners with appropriate Drug Enforcement Administration registration and prescribing authority can prescribe buprenorphine for opioid use disorder subject to applicable state requirements. The old buprenorphine waiver and federal patient caps should therefore not be treated as current barriers.
Methadone maintenance and opioid treatment programs
Methadone is a full opioid agonist that has been used for decades to treat opioid dependence and opioid use disorder. When appropriately dosed, methadone can relieve withdrawal, reduce cravings, and help stabilize patterns of opioid use.
Federal rules for methadone differ from those for buprenorphine. Methadone used to treat OUD is generally dispensed through certified opioid treatment programs rather than through a standard outpatient prescription.
Methadone maintenance can continue for different lengths of time depending on the individual. There is no universal point at which someone must become opioid-free or discontinue medication simply because a certain number of months or years have passed.
Naltrexone and extended-release injectable suspension
Naltrexone is an opioid antagonist, meaning it blocks opioid receptors rather than activating them. It can prevent the euphoric effects of opioids and may help reduce the risk of returning to opioid use after a person has completed an opioid-free period.
For opioid use disorder, naltrexone is available as an extended-release injectable suspension. Because naltrexone can precipitate severe withdrawal if opioids remain in the body, medical professionals confirm an adequate opioid-free interval before treatment begins.
Naltrexone is also used to treat alcohol use disorder, although its role in alcohol treatment differs because alcohol does not act directly on opioid receptors in the same way as illicit opioids.

We accept most insurance plans
Medication-assisted treatment for alcohol use disorder
Medication can also be used to treat alcohol use disorder. In the United States, three medications are FDA-approved for AUD: naltrexone, acamprosate, and disulfiram.
Naltrexone can help reduce alcohol cravings and the rewarding effects associated with drinking. Acamprosate can support continued abstinence after alcohol consumption stops. Disulfiram works differently by producing an unpleasant physical reaction if alcohol is consumed.
These medications do not replace medical management of alcohol withdrawal. Someone with significant alcohol dependence may require medical supervision during withdrawal before beginning longer-term addiction treatment. Medication choice also depends on medical conditions, current alcohol consumption, other medications, and treatment goals.
MAT treatment, cravings, and brain chemistry
Substance use can change the brain’s reward, stress, and learning pathways over time. MAT medications may help stabilize some of the biological processes affected by repeated opioid or alcohol use, but describing treatment as simply “fixing brain chemistry” oversimplifies addiction.
For many patients, the practical benefits are easier to see in reduced cravings, fewer withdrawal symptoms, more stable routines, and greater ability to focus on recovery. Medication may make it easier to participate in counseling, employment, family responsibilities, and other parts of daily life that were disrupted by substance misuse.
Medication can also support treatment retention. For opioid use disorder in particular, methadone and buprenorphine have strong evidence supporting their role in reducing illicit opioid use and lowering mortality.
Addiction treatment beyond medication
Medication-assisted treatment is not limited to taking a prescription. A broader addiction treatment plan may also address mental health, housing, relationships, employment, physical health, relapse risk, and other factors that influence recovery.
Behavioral therapies may help people identify substance-use triggers, improve coping strategies, and change patterns that contribute to relapse. Cognitive behavioral therapy is one approach that may be used alongside medication, although medication for OUD should not be withheld simply because counseling is unavailable or declined.
Support may also include family involvement, peer recovery resources, medical follow-up, vocational assistance, and help managing conditions such as hepatitis C or other health concerns associated with injection drug use.
Medication-assisted treatment and dual diagnosis
Opioid use disorder and alcohol use disorder frequently occur alongside depression, anxiety, PTSD, bipolar disorder, and other mental health conditions. Psychological cravings, stress, trauma, and untreated psychiatric symptoms can all affect substance use and recovery.
When a substance use disorder occurs alongside another psychiatric condition, understanding how dual diagnosis treatment centers in Kentucky approach co-occurring needs can provide useful context. Medication for addiction may address opioid cravings or alcohol cravings while separate psychiatric treatment addresses depression, anxiety, trauma, or another mental health disorder.
A coordinated treatment plan can also reduce the risk of medications working at cross-purposes or important symptoms being attributed to substance use when another medical or psychiatric condition is contributing.
Medical assessment before starting MAT medications
Medication treatment should be individualized rather than chosen from a standard formula. Before someone begins methadone, buprenorphine, naltrexone, acamprosate, disulfiram, or another medication, healthcare practitioners consider the substance being used, current withdrawal symptoms, medical history, psychiatric history, and other prescriptions.
An assessment may consider:
- Current substance use. The type of opioids or alcohol being used, frequency, amount, and recent use.
- Withdrawal and overdose history. Previous severe withdrawal, opioid overdose, or return to use after periods of abstinence.
- Medical conditions. Liver, kidney, cardiac, infectious, or other health concerns that may influence medication choice.
- Mental health. Depression, anxiety, trauma, suicidality, or other psychiatric symptoms that may affect treatment.
- Treatment goals and preferences. Previous medication experiences, access, comfort with different formulations, and plans for long-term recovery.
Ongoing medical supervision allows the medication plan to change as symptoms, health, and recovery goals change.
How long medication treatment may last
There is no single correct duration for medication-assisted treatment. Some people use medication for months, while others benefit from treatment lasting several years or longer.
For opioid use disorder, stopping methadone or buprenorphine prematurely can lead to renewed withdrawal, cravings, and return to opioid use. Decisions about reducing or discontinuing medication should therefore be made gradually with a medical provider rather than according to an arbitrary timeline.
Long-term medication treatment is not evidence that recovery has failed. For many people, remaining stable, reducing overdose risk, rebuilding relationships, and maintaining work or family responsibilities are meaningful measures of sustained recovery.
Insurance coverage for medication-assisted treatment
Many health insurance plans include benefits for substance use disorder treatment and prescription medications, but coverage for specific MAT medications, opioid treatment programs, counseling, and levels of care varies by plan.
The Mental Health Parity and Addiction Equity Act requires many health plans that provide mental health and substance use disorder benefits to apply coverage rules that are comparable to those used for medical and surgical benefits. The law does not mean every plan covers every treatment or medication, so individual benefits still need to be reviewed.
Prior authorization, formulary requirements, network restrictions, deductibles, and copayments may affect access. Someone seeking treatment can review plan documents or contact the insurer directly to understand which medications and services are covered.
Different treatment pathways with MAT
Medication-assisted treatment can be used across different treatment pathways rather than belonging to one single level of care. Someone may begin medication during withdrawal management, in an opioid treatment program, through outpatient medical care, or as part of a more structured addiction treatment setting.
Inpatient treatment, residential care, partial hospitalization, intensive outpatient treatment, and standard outpatient care differ in structure and clinical intensity. The presence of MAT medication alone does not determine which level is appropriate.
The appropriate setting depends on factors such as overdose risk, medical stability, withdrawal symptoms, mental health, housing, substance use severity, and the amount of support available outside treatment.
Medication-assisted treatment and long-term recovery
Medication can help reduce some of the physical and psychological pressures that make early recovery difficult, but long-term recovery is broader than medication alone. Stability can also involve rebuilding relationships, treating medical and mental health conditions, developing healthier routines, and creating a sustainable support system.
People receiving treatment should not be expected to prove recovery by stopping medication before they are clinically ready. For opioid use disorder, continuing evidence-based medication can reduce overdose risk and help sustain recovery over time.
The goal is not simply to become medication-free. The goal is safer, healthier functioning and a treatment approach that supports the individual’s long-term well-being.
Get fast answers to your questions

FAQs
What is medication-assisted treatment (MAT), and how does it work?
Medication-assisted treatment (MAT) combines FDA-approved medications with individualized recovery support to help treat substance use disorders. Commonly prescribed medications relieve physical symptoms of withdrawal, reduce cravings, or block certain drug effects.
For opioid use disorder (OUD), medications include methadone, buprenorphine, and naltrexone. This approach addresses the physical aspects of opioid addiction while allowing a treatment team to consider mental health, counseling, and other recovery needs.
How effective is MAT for opioid addiction treatment?
Medication-assisted treatment is an evidence-based approach to opioid addiction treatment that can reduce opioid misuse and the risk of overdose deaths. Research shows that medications, particularly methadone and buprenorphine, are associated with substantially lower mortality among people with opioid use disorder.
The U.S. Department of Health and Human Services recognizes medication treatment as an important part of reducing opioid-related overdose deaths. Comparative effectiveness varies by medication, treatment retention, and individual circumstances.
What medications are used for opioid addiction, and how are they different?
Methadone is a full opioid agonist, while buprenorphine is a partial agonist that helps reduce withdrawal and cravings. Buprenorphine can reduce risk when used as prescribed, and some formulations combine it with naloxone to discourage injection misuse. People who cannot tolerate naloxone should discuss alternative formulations with their prescriber.
Naltrexone blocks opioid receptors and requires an appropriate opioid-free period before treatment begins. Addiction medicine continues to evolve, with newer FDA-approved medication formulations offering additional dosing options rather than entirely new medication categories.
Does health insurance cover medication-assisted treatment?
Most health insurance plans may offer some coverage for substance abuse treatment, including medications used for opioid use disorder. However, coverage depends on the insurer, specific medication, treatment setting, and individual policy.
Before beginning treatment, patients should verify benefits, prescription coverage, prior authorization requirements, and potential out-of-pocket costs. Access to medication may also vary in rural areas where fewer specialized providers are available.
Can MAT support long-term recovery from drug abuse and opioid misuse?
Yes. MAT can support long-term recovery by reducing withdrawal symptoms, cravings, and the risk of returning to opioid use. Unlike short-term withdrawal management, medication treatment may continue for months or years when clinically appropriate.
A comprehensive assessment helps determine which medication is suitable. The treatment team can also address co-occurring anxiety, depression, trauma, or other mental health concerns while helping individuals build a sustainable recovery plan.
Rehab might feel like a big step, but it's important to remember why you're here—you’re seeking answers and looking for a way forward. We can help.
Understanding medication-assisted treatment in Kentucky
For people living with opioid use disorder or alcohol use disorder, medication may provide meaningful support as part of an individualized recovery plan. Understanding the available options, possible risks, and role of ongoing care can help individuals make informed decisions with their healthcare providers. Kentucky Addiction Treatment provides educational resources for individuals and families exploring addiction treatment, mental health, and recovery options throughout Kentucky. If you have questions about medication-assisted treatment or want to better understand available approaches, contact us by calling (888) 771-8718.
For additional information or to find addiction treatment and mental health services in your area, contact us directly or visit SAMSHA’s treatment locator. For immediate assistance, call or text 988 to reach the National Suicide & Crisis Lifeline or (888) 771-8718 to speak to a treatment specialist at our Kentucky rehab.
View Article References
- Substance Abuse and Mental Health Services Administration. (2024). TIP 63: Medications for opioid use disorder.
- Substance Abuse and Mental Health Services Administration. (2026). Waiver elimination (MAT Act).
- Centers for Disease Control and Prevention. (2024). Opioid use disorder: Treating.
- National Institute on Alcohol Abuse and Alcoholism. (n.d.). Treatment for alcohol problems: Finding and getting help.
- U.S. Department of Labor. (n.d.). Understanding your mental health and substance use disorder benefits.
Key Takeaways
- Medication-assisted treatment, or MAT, can help people who are dealing with opioid or alcohol use disorder.
- This type of treatment uses medication as one part of a complete recovery plan, which is created just for you.
- It is important to talk with a healthcare provider to learn about your options and decide if this treatment is the right choice for your recovery.